GSK melanoma pill backed by UK cost watchdog with price cut
September 17, 2014 at 19:01 PM EDT
LONDON, Sept 18 (Reuters) - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.